We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $936M
1-Year Est. Return 195%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$3.62B
AUM Growth
+$540M
Cap. Flow
+$569M
Cap. Flow %
15.72%
Top 10 Hldgs %
34.44%
Holding
132
New
36
Increased
34
Reduced
15
Closed
38

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$105M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$93.1M
3
MDT icon
Medtronic
MDT
+$84.8M
4
NUVB icon
Nuvation Bio
NUVB
+$84.1M
5
ABBV icon
AbbVie
ABBV
+$77.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$137M
2
DGX icon
Quest Diagnostics
DGX
+$94.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$87.1M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$57.5M
5
ORGO icon
Organogenesis Holdings
ORGO
+$55M

Sector Composition

Rank Sector Weight
1 Healthcare 95.31%
2 Financials 0.29%
3 Industrials 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACCD
126
DELISTED
Accolade Inc
ACCD
– –
-40,000
Closed -$1.74M
RETA
127
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-125,690
Closed -$15.5M
OSH
128
DELISTED
Oak Street Health, Inc.
OSH
– –
-150,000
Closed -$9.17M
ALBO
129
DELISTED
Albireo Pharma Inc
ALBO
– –
-125,000
Closed -$4.69M
CHNG
130
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-3,082,100
Closed -$57.5M
FPRX
131
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-300,000
Closed -$5.1M
PANA.U
132
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
– –
-300,000
Closed -$3.83M
2 3 4 5
6

Similar funds

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Avidity Partners Management's Q1 2021 Portfolio in Review

As of Q1 2021, Avidity Partners Management held 132 positions worth $3.62B, up 18% from $3.08B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Avidity Partners Management deployed $569M of net new capital in Q1 2021, opening 36 new positions and adding to 34 existing holdings. Its largest new stake was Intuitive Surgical: 418,200 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Organogenesis Holdings, an estimated $55M trimmed.

  • Avidity Partners Management's largest Q1 2021 buy was Intuitive Surgical: 418,200 shares worth $103M.
  • Avidity Partners Management added most to Medtronic in Q1 2021, an estimated $84.8M increase.
  • Avidity Partners Management's biggest Q1 2021 reduction was Organogenesis Holdings, cutting an estimated $55M.
  • Avidity Partners Management fully exited Eli Lilly in Q1 2021, selling an estimated $137M.
  • Avidity Partners Management's ten largest holdings make up 34% of its $3.62B portfolio in Q1 2021.
  • Avidity Partners Management opened 36 new positions and closed 38 in Q1 2021.
  • Avidity Partners Management's portfolio value rose 18% quarter-over-quarter to $3.62B.

Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.